Patent · US Active

Live attenuated strains of foot and mouth disease modified by deoptimization and uses thereof

US11793870B2 · kind B2 · utility

0Cited by

2References

32Claims

0Family size

Assignees

Inventors

Teresa B. De Los Santos · Miller Place, US
Aida Elizabeth Rieder · Westbrook, US
Fayna C. Diaz-San Segundo · Lakeland, US
Anna Kloc · Guilford, US
John Robert Coleman · New York, US
Steffen Mueller · Pforzheim, DE
Gisselle N. Medina · Sound Beach, US

Key dates

Filing date	May 26, 2021
Grant date	Oct 24, 2023
Priority date	—
Expiry date	Jan 4, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2770/32134
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure describes deoptimized foot and mouth viruses and their use for prophylactic and therapeutic treatment of mammalian subjects. The recombinant viruses provided herein include alterations in several genomic regions as well as Differentiating Infected from Vaccinated Animals (DIVA) markers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.